Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Rheumatoid arthritis More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Chondroitin Sulfate / Glucosamine Hydrochloride More
A vector to be used for transfection and purification of human soluble FcRn receptor More
immuno-suppresant agent More
Low Concentration Hypochlorous Acid Producing Technology More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
Dec 2010 - 37 pages - $500
Jan 2010 - $75
Jan 2011 - 34 pages - $500
Nov 2010 - 40 pages - $500
May 2011 - 15 pages - $250
Apr 2011 - 75 pages - $3,800
Dec 2010 - 22 pages - $500
Oct 2011 - 113 pages - $2,795
Jul 2011 - 136 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us